Eikon Therapeutics snares $500M series B, pinning constellation of biotech stars to its upper ranks fkansteiner Wed, 01/05/2022 - 15:18.: Eikon Therapeutics, the drug discovery startup with a former Merck & Co. research chief at the helm, has appointed a pantheon of biotech veterans on its quest to take its live-cell imaging platform to the next level. The biotech unveiled the hiring of six new executives as it pulled back the curtain on a more than half-a-billion-dollar fundraising round Thursday.